Apira Science said that the FDA has granted the company over-the- counter clearance for its iGrow Hair Growth System to effectively promote hair growth in women with Fitzpatrick skin phototypes I to IV and with Ludwig Baldness Scale Classifications of I to II. "More than 40 million women suffer from genetic hair loss, yet iGrow is one of just a ha
USP offered the Federal Trade Commission and FDA background information on the manner in which chemical and biologic drugs are named, also underscoring to FDA that compendial identity is different from regulatory identity. USP encouraged FDA to allow for alternative approaches to validation of analytical procedures and methods:' USP values its role
PETACH TIKVA, Israel, Dec. 31, 2013/ PRNewswire/ Can-Fite BioPharma Ltd.,, a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today the following:. The Company's subsidiary, OphthaliX Inc., will conduct a retrospective analysis of its Phase III Dry Eye Syndrome stud
THREE AND SIX MONTHS ENDED SEPTEMBER 30, 2015. The following discussion and analysis should be read with the financial statements and accompanying notes included elsewhere in this Form 10- Q and in the Annual Report on Form 10- K for the year ended March 31, 2015. Without limiting the broader description of forward-looking statements above, we spec
Nutra Pharma Corporation, a biotechnology company marketing Nyloxin and Pet Pain-Away in the over-the-counter pain management market, and which is also developing treatments for Multiple Sclerosis, Human Immunodeficiency Virus, Adrenomyeloneuropathy and Pain, announced today that the Company's Chief Executive Officer, Rik J Deitsch, has publishe
By a News Reporter-Staff News Editor at Biotech Week Valeant Pharmaceuticals International, Inc. announced new fulfillment agreements with Walgreens while indicating it intends to extend this distribution model to additional participating independent retail pharmacies. In conjunction with the fulfillment agreement, Valeant will reduce prices of..
AVACEN Medical announced today that it has launched a $2 million campaign on Crowdfunder.com to support further company clinical trials and FDA applications. The research studies evaluated an investigational device that is not cleared by the FDA for the treatment of fibromyalgia. Pre- and post-treatment evaluations were conducted at the UCSD Pain
The Consumer Reports survey goes further to uncover consumer confusion about the safety and effectiveness of these products with 20% of respondents saying they thought that the FDA tests and guarantees the safety and effectiveness of supplements. In fact, the FDA regulates supplements much like foods, meaning they're generally considered safe unles
New York, NY December 29, 2014 OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com. Today's alerts include: Aoxing Pharmaceutical Company, Inc.; last trade. 31 Aox
New York, NY December 29, 2014 OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Today's alerts include: Bristol-Myers Squibb; last trade 59.84 Bristol-Myers Squibb is a global pharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over ser
New York, NY December 29, 2014 OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Today's alerts include: Catalyst Pharmaceuticals; last trade 2.92 Catalyst Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseas
Today's alerts include: Cellceutix; last trade 4.21 Headquartered in Beverly, Massachusetts, Cellceutix is a publicly traded company under the symbol "CTIX". Cellceutix is a clinical stage biopharmaceutical company developing innovative therapies in oncology, dermatology and antimicrobial applications. Cellceutix's anti-cancer drug Kevetrin is...
New York, NY December 29, 2014 OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Today's alerts include: Columbia Laboratories, Inc; last trade 5.60 Columbia Laboratories, Inc. is a pharmaceutical development company providing formulation development, clinical trial manufacturing, and advanced analytical
New York, NY December 29, 2014 OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Today's alerts include: Dynavax,; last trade 16.16 Dynavax, a clinical-stage biopharmaceutical company, uses TLR biology to discover and develop novel vaccines and therapeutics in the areas of infectious and inflammatory dise
Today's alerts include: Impax Laboratories, Inc.; last trade 31.84 Impax Laboratories, Inc. is a technology based specialty pharmaceutical company applying its formulation expertise and drug delivery technology to the development of controlled-release and specialty generics in addition to the development of central nervous system disorder branded..
?USP offered the Federal Trade Commission and FDA background information on the manner in which chemical and biologic drugs are named, also underscoring to FDA that compendial identity is different from regulatory identity. "?USP encouraged FDA to allow for alternative approaches to validation of analytical procedures and methods:" USP values
Walgreens is principally a retail drugstore chain that sells prescription and non-prescription drugs and general merchandise. At November 30, 2014, we operated 8,330 locations in 50 states, the District of Columbia, Puerto Rico, and the U.S. Virgin Islands. Total locations do not include 430 Healthcare Clinics and 46 worksite pharmacies, which oper
Acura Pharmaceuticals, Inc. entered into a Loan and Security Agreement with Oxford Finance LLC, pursuant to which Oxford agreed to make a term loan to the Company in the principal amount of $10.0 million. About Acura Pharmaceuticals Acura Pharmaceuticals is a specialty pharmaceutical company engaged in the research, development and commercializatio
EVENT: Health and Human Services Department; Food and Drug Administration holds a hearing to obtain information on the formulation, manufacturing, and labeling of currently marketed over-the-counter emergency first aid eyewash drug products, including the components of these products, and the conditions under which such products are safe and effect
Developing at an impressive CAGR of 16.40% from 2013 to 2019, the wearable medical devices market is only going to expand over the next coming years, according to Transparency Market Research. A new report by the market intelligence company states that the global wearable medical devices market is projected to grow from a value of US $2 bn in 2012
By a News Reporter-Staff News Editor at Clinical Trials Week Apira Science, Inc. announced the FDA has granted the company over-the-counter clearance for its iGrow Hair Growth System to effectively promote hair growth in women with Fitzpatrick skin phototypes I to IV and with Ludwig Baldness Scale Classifications of I to II. "More than 40 mil
Strategic Science and Technologies Signs Partnership Agreement with a Leading Global Pharmaceutical Company for U.S. By a News Reporter-Staff News Editor at Clinical Trials Week Strategic Science and Technologies LLC announced the signing of an option agreement with one of the world's largest over-the-counter healthcare companies.
By a News Reporter-Staff News Editor at Mental Health Weekly Digest From Alexandria, Virginia, NewsRx journalists report that a patent by the inventors Howard, William Wayne; Kavesh, Sheldon; Somma, Russell Francis, filed on February 14, 2012, was published online on December 15, 2015. The patent's assignee for patent number 9211292 is ALITAIR PH
With just four trading sessions to go in CY 2015, the Indian pharma sector has found on a roller-coster ride with big companies like Sun Pharma and Dr. Reddy's Lab made the headlines with some positive and some negative reasons. outperforming the biggies, several small pharma companies have given robust returns to their investors, as high as 1550%
By a News Reporter-Staff News Editor at Investment Weekly News OTC Markets Group Inc., operator of Open, Transparent and Connected financial marketplaces, announced that Anavex Life Sciences Corp., a clinical-stage biopharmaceutical company developing novel drug candidates to treat Alzheimer's disease, other diseases of the central nervous system